CYTK Cytokinetics, Incorporated logo

CYTK Cytokinetics, Incorporated

Healthcare
$76.29-0.84%ClosedMarket Cap: $9.49B

As of 2026-05-26

Institutional Ownership Summary

Investors Holding

470

13F Shares

138,460,387

Ownership %

115.4%

New Positions

100

Increased Positions

252

Closed Positions

56

Reduced Positions

130

ETF Exposure
ETF SymbolETF NameShares HeldWeight %
FMEDFidelity Disruptive Medicine ETF13,2231.51%
JSMDJanus Henderson Small/Mid Cap Growth Alpha ETF177,3021.44%
XBI1,331,4531.21%
JSMLJanus Henderson Small Cap Growth Alpha ETF48,3381.17%
VETS21,5891.10%
VIRS21,5891.10%
SLTPacer Salt High truBeta US Market ETF21,5891.10%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF21,5891.10%
LSLTPacer Salt Low truBeta US Market ETF21,5891.10%
TCAFT. Rowe Price Capital Appreciation Equity ETF1,045,1021.08%
VALT28,7580.94%
GSCGoldman Sachs Small Cap Equity ETF21,6430.92%
LABUDirexion Daily S&P Biotech Bull 3X ETF66,6940.85%
TCALT. Rowe Price Capital Appreciation Premium Income ETF32,9740.78%
IBBiShares Biotechnology ETF896,9720.73%
VGHAX4,050,6670.65%
VGHCX4,050,6670.65%
IWNiShares Russell 2000 Value ETF912,9720.47%
NAJ912,9720.47%
ETHOAmplify Etho Climate Leadership U.S. ETF10,6930.45%